iCAD vs Neuroscreen
iCAD vs Neuroscreen, compared side by side on 11 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: iCAD is on 55/100 and Neuroscreen on 7/100.
Where each one leads
iCAD
- our overall score: 55/100 against 7/100
- agent readiness: 39/100 against 21/100
Neuroscreen
Leads on none of the measures we hold for both companies.
At a glance
| Measure | iCAD | Neuroscreen |
|---|---|---|
| What it is | AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment. | Neuroscreen develops AI-powered tools for early detection and monitoring of neurodegenerative diseases. |
| Category | MedTech, HealthTech, AI-Driven Protein Design, Clinical Trials | MedTech, HealthTech, Neurotech, AI Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 1984 | 2026 |
| Headquarters | Nashua, United States | Grays, England |
| Status | Active | Active |
Size, funding and growth
| Measure | iCAD | Neuroscreen |
|---|---|---|
| Employees | 353 | Not published |
| Headcount growthLast 12 months | +26.6% | Not published |
| Total funding | $113M | Not published |
| Latest round | Direct Offering | Not published |
| LinkedIn followers | 15,268 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | iCAD | Neuroscreen |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 7/100 |
| Traction | 58/100 | Not published |
| Team | 50/100 | Not published |
| Search visibility | 33/100 | 2/100 |
| Quality | 58/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 53/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | iCAD | Neuroscreen |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Ghost | Not detected |
| Open source | No | Yes |
iCAD vs Neuroscreen: common questions
Which is better, iCAD or Neuroscreen?
On our 0-100 score iCAD rates higher (55/100 against 7/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 11 data points above: read the rows that match what you are buying for.
How do iCAD and Neuroscreen compare on the numbers?
iCAD leads on our overall score (55/100 against 7/100), agent readiness (39/100 against 21/100).
Read the full iCAD review and pricing or the Neuroscreen review and pricing. You can also browse other iCAD alternatives we track.